Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
RTW Investments
AddedFeb 13, 2024
UpdatedJun 28, 2026
RTW Investments

RTW Investments

Operating

RTW Investments, a healthcare investment firm, partners with innovative health companies.

Location
New York City, NY, US
Founded
2010
Firm
Compare
Portfolio
Employees

RTW Investments invests with

innovative health care companies.

RTW Investments - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments41
Current Portfolio Count32
Total Portfolio Exits1

Top Investment Stages

Series B14 (37.8%)
Post Ipo Equity9 (24.3%)
Series C7 (18.9%)
Series D4 (10.8%)
Series Unknown3 (8.1%)

Stage Mix

Series B 38%Post Ipo Equity 24%Series C 19%Series D 11%Series Unknown 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

City Therapeutics logo

City Therapeutics

Basking Biosciences logo

Basking Biosciences

Arvinas logo

Arvinas

SAB Biotherapeutics logo

SAB Biotherapeutics

Beta Bionics logo

Beta Bionics

Taysha Gene Therapies logo

Taysha Gene Therapies

Kyverna Therapeutics logo

Kyverna Therapeutics

2seventy bio logo

2seventy bio

Magnolia Medical Technologies logo

Magnolia Medical Technologies

Roivant Sciences logo

Roivant Sciences

Lycia Therapeutics logo

Lycia Therapeutics

Inbrace logo

Inbrace

Whitehawk Therapeutics logo

Whitehawk Therapeutics

Neurogastrx logo

Neurogastrx

Umoja Biopharma logo

Umoja Biopharma

Alcyone Lifesciences logo

Alcyone Lifesciences

NiKang Therapeutics logo

NiKang Therapeutics

Numab logo

Numab

NeoGenomics Laboratories logo

NeoGenomics Laboratories

UroGen Pharma logo

UroGen Pharma

Visus Therapeutics logo

Visus Therapeutics

Artiva Biotherapeutics logo

Artiva Biotherapeutics

Encoded Therapeutics logo

Encoded Therapeutics

Cogent Biosciences logo

Cogent Biosciences

C4 Therapeutics logo

C4 Therapeutics

RTW Investments - Similar Investment Firms

RTW Venture Fund logo

RTW Venture Fund

RTA Capital logo

RTA Capital

GT Healthcare Capital Partners logo

GT Healthcare Capital Partners

Whistler Capital Partners logo

Whistler Capital Partners

RTC Partners logo

RTC Partners

rtcpartners.com

Swiftarc Ventures logo

Swiftarc Ventures

RTK Group logo

RTK Group

rtkgrp.com

Rtaventures VC logo

Rtaventures VC

RW Capital Partners logo

RW Capital Partners

rwpartners.com

TWB Investment logo

TWB Investment

Wittington Ventures logo

Wittington Ventures

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

RFT Investment Company logo

RFT Investment Company

Invicta Management logo

Invicta Management

Rtp-Hc logo

Rtp-Hc

rtp.vc

RTW Investments - Classification

Also Known As
  • RTW Investments, LP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end